Recombinant human CD229/SLAMF3 protein from NKMAX Co. Ltd.

Search, find, compare suppliers for Recombinant human CD229/SLAMF3 protein products.

Edit 
Product NameRecombinant human CD229/SLAMF3 protein
DescriptionDomain: 48-454aa. Recombinant human LY9, fused to His-tag at C-terminus, was expressed in insect cell and purified by using conventional chromatography techniques. MW: 45.9 kDa (416aa). Purity > 90% by SDS-PAGE. LY9, as known as T-lymphocyte surface antigen Ly-9 isoform, is a type 1 transmembrane glycoprotein in the SLAM subgroup of the CD2 family. This protein consists of an extracellular domain with two lg-like V-set and two lg-like truncated C2-set domains. It is expressed on T and B cells, thymocytes, and more weakly on NK cells. Homophilic binding between LY9 molecules is mediated by the N-terminal lg-like domain. Also, this protein knockout mice show minimally impaired immune responses, suggesting functional redundancy with other molecules
Size10ug, 50ug
Concentration0.25mg/ml (determined by absorbance at 280nm)
ApplicationsSDS-PAGE
Other NamesT-lymphocyte surface antigen Ly-9 isoform, LY9, CD229, hly9, mLY9, SLAMF3, CD229 Cell surface molecule Ly-9, Cell surface molecule Ly9, hly9, LY 9, Ly9, LY9_HUMAN, Lymphocyte antigen 9, mLY9, Signaling lymphocytic activation molecule 3, SLAM family member 3, SLAMF3, T lymphocyte surface antigen Ly9 precursor, T-lymphocyte surface antigen Ly-9
Gene, Accession, CAS #NCBI: NP_002339, UniProt: Q9HBG7
Catalog #ATGP3400
Price$240, $960
Order / More InfoRecombinant human CD229/SLAMF3 protein from NKMAX Co. Ltd.
Product Specific Referencesn/a
NKMAX Co. Ltd.
NKMAX Co. Ltd.
NKMAX Co. Ltd.
6F, SNUH Health Care Innovation Park
172 Dolma-ro, Bundang-gu
Seongnam-si, Gyeonggi-do 13605 REPUBLIC OF KOREA
P: +82-31-8017-8114
F: +82-31-8017-8124

salesbio@nkmax.com

http://www.nkmaxbio.com

Profile of NKMAX Co. Ltd.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.